Concepedia

Author

Mark Gardner

Pfizer (United States)

Also Known As

Gardner M, Gardner, Mark, M Gardner, M J Gardner, M. Gardner, M. J. Gardner, M.J. Gardner, MARK J. GARDNER, Mark Gardner, Mark J Gardner

56

Publications

2.2K

Citations

20

H-Index

92

Concepts

All Affiliations

Pfizer (United States)Roswell Park Comprehensive Cancer CenterDélégation Paris 5Université Paris CitéCornell University
MG

About

Mark Gardner is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

14

1.1K

2

Social Sciences

2

2

328

3

Engineering

1

1

44

4

Health Sciences

1

1

64

5

Natural Sciences

1

1

18

Mark Gardner

×

32

Publications

2.2K

Citations

20

H-Index

YearCitations

Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol

William J. Jusko, Mark Gardner, Antoinette Mangione,

Journal of Pharmaceutical Sciences

1979

251

Attention Deficit Disorder and Methylphenidate: Normalization Rates, Clinical Effectiveness, and Response Prediction in 76 Children

Mark D. Rapport, Colin B. Denney, George J. DuPaul,

Journal of the American Academy of Child & Adolescent Psychiatry

1994

235

Increased Gastric pH and the Bioavailability of Fluconazole and Ketoconazole

Robert A. Blum, David T. D'Andrea, Becky M. Florentino,

Annals of Internal Medicine

1991

167

Enhanced biotransformation of theophylline in marihuana and tobacco smokers

William J. Jusko, Jerome J. Schentag, John H. Clark,

Clinical Pharmacology & Therapeutics

1978

163

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Carl Morrison, Sarabjot Pabla, Jeffrey M. Conroy,

Journal for ImmunoTherapy of Cancer

2018

149

Effect of fluconazole on the disposition of phenytoin

Robert A. Blum, J WILTON, Donald M. Hilligoss,

Clinical Pharmacology & Therapeutics

1991

119

INTERACTION BETWEEN CYCLOSPORINE AND FLUCONAZOLE IN RENAL ALLOGRAFT RECIPIENTS

Daniel M. Canafax, Nina M. Graves, Donald M. Hilligoss,

Transplantation

1991

107

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

Sarabjot Pabla, Jeffrey M. Conroy, Mary Nesline,

Journal for ImmunoTherapy of Cancer

2019

106

Attention Deficit Disorder and Methylphenidate: Group and Single-Subject Analyses of Dose Effects on Attention in Clinic and Classroom Settings

Mark D. Rapport, Janice Jones, George J. DuPaul,

Journal of Clinical Child Psychology

1987

93

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

Jeffrey M. Conroy, Sarabjot Pabla, Mary Nesline,

Journal for ImmunoTherapy of Cancer

2019

87

Page 1